{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:36:55Z","timestamp":1791909415786,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":4171,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1046\/j.1469-0691.2003.00552.x","type":"journal-article","created":{"date-parts":[[2003,7,28]],"date-time":"2003-07-28T10:10:07Z","timestamp":1059387007000},"page":"585-589","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Determination of pertactin IgG antibodies for the diagnosis of pertussis"],"prefix":"10.1016","volume":"9","author":[{"given":"B.","family":"Trollfors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Lagerg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Taranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2003.00552.x_bib1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/infdis\/163.5.1046","article-title":"Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial","volume":"163","author":"Hallander","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00006454-199306000-00009","article-title":"Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany","volume":"12","author":"Heininger","year":"1993","journal-title":"Pediatr Infect Dis J"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib4","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/JCM.36.3.679-683.1998","article-title":"Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections","volume":"36","author":"Lind-Brandberg","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib5","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1542\/peds.105.3.e31","article-title":"Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial","volume":"105","author":"Heininger","year":"2000","journal-title":"Pediatrics"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib6","series-title":"WHO meeting on case definitions of pertussis, Geneva, Switzerland, January 10\u201311, 1991. MIN\/EPI\/PERT\/91.1","author":"World Health Organization","year":"1991"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0264-410X(90)90246-I","article-title":"Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial","volume":"8","author":"Storsaeter","year":"1990","journal-title":"Vaccine"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib8","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1086\/515172","article-title":"Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis","volume":"28","author":"Trollfors","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib9","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00006454-198704000-00005","article-title":"Pertussis in Sweden after the cessation of general immunization in 1979","volume":"6","author":"Romanus","year":"1987","journal-title":"Pediatr Infect Dis J"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/00365549509019021","article-title":"Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis","volume":"27","author":"Isacson","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0022-1759(95)00067-K","article-title":"Comparison of five calculation modes for antibody ELISA procedures ussing pertussis serology as a model","volume":"183","author":"Reizenstein","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.171.1.63","article-title":"Characterization of the protective capacity and immunogenicity of the 69 kDa protein of Bordetella pertussis","volume":"171","author":"Shahin","year":"1990","journal-title":"J Exp Med"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.101.1.1","article-title":"A comparative efficacy trial in Germany in infants who received either the Lederle\/Takeda acellular pertussis component (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine","volume":"101","author":"Stehr","year":"1998","journal-title":"Pediatrics"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S1201-9712(99)90035-8","article-title":"Parapertussis and pertussis. Differences and similarities in incidence, clinical course and antibody responses","volume":"3","author":"Bergfors","year":"1999","journal-title":"Int J Infect Dis"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00006454-199506000-00009","article-title":"Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis","volume":"14","author":"Isacson","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1046\/j.1469-0691.2003.00552.x_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1469-0691.1999.tb00520.x","article-title":"Acquisition of serum antibodies against filamentous hemagglutinin and pertactin unrelated to Bordetella pertussis infection","volume":"5","author":"Carlsson","year":"1999","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1463946X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1463946X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:18:13Z","timestamp":1761117493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1463946X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["S1198743X1463946X"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00552.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2003,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of pertactin IgG antibodies for the diagnosis of pertussis","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2003.00552.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}